Comparison of clinicopathological characteristics, gene expression profiles, mutational analysis, and clinical outcomes of pure and mixed small‐cell carcinoma of the bladder
暂无分享,去创建一个
E. Compérat | D. McConkey | M. Kates | W. Choi | N. Hahn | J. Hoffman-Censits | A. Matoso | Vamsi Parimi | M. Fong | Mingxiao Feng | Rodrigo Salgado Esteves | Kara A Lombardo
[1] D. McConkey,et al. Update on bladder cancer molecular subtypes , 2020, Translational andrology and urology.
[2] P. Pierorazio,et al. Clinical Restaging and Tumor Sequencing are Inaccurate Indicators of Response to Neoadjuvant Chemotherapy for Muscle-invasive Bladder Cancer. , 2020, European urology.
[3] G. Cancel-Tassin,et al. Urothelial Cancers with Small Cell Variant Histology Have Confirmed High Tumor Mutational Burden, Frequent TP53 and RB Mutations, and a Unique Gene Expression Profile. , 2020, European urology oncology.
[4] C. Jackson,et al. Analysis of Intestinal Metaplasia Without Dysplasia in the Urinary Bladder Reveal Only Rare Mutations Associated With Colorectal Adenocarcinoma , 2019, Applied immunohistochemistry & molecular morphology : AIMM.
[5] A. Lopez‐Beltran,et al. Variants and new entities of bladder cancer , 2018, Histopathology.
[6] H. Williams,et al. The oncological outcomes of small cell carcinoma of the bladder. , 2018, Canadian Urological Association journal = Journal de l'Association des urologues du Canada.
[7] G. Iyer,et al. Updates on the Genetics and Molecular Subtypes of Urothelial Carcinoma and Select Variants. , 2018, Surgical pathology clinics.
[8] B. Czerniak,et al. Small cell carcinoma of the urinary bladder: a clinicopathological and immunohistochemical analysis of 81 cases. , 2018, Human pathology.
[9] N. Socci,et al. Small-Cell Carcinomas of the Bladder and Lung Are Characterized by a Convergent but Distinct Pathogenesis , 2017, Clinical Cancer Research.
[10] Steven J. M. Jones,et al. Comprehensive Molecular Characterization of Muscle-Invasive Bladder Cancer , 2017, Cell.
[11] J. Warrick. Clinical Significance of Histologic Variants of Bladder Cancer. , 2017, Journal of the National Comprehensive Cancer Network : JNCCN.
[12] J. Epstein,et al. Sarcomatoid carcinoma associated with small cell carcinoma of the urinary bladder: a series of 28 cases. , 2017, Human pathology.
[13] S. Lipsitz,et al. Effect of Nonurothelial Histologic Variants on the Outcomes of Radical Cystectomy for Nonmetastatic Muscle‐invasive Urinary Bladder Cancer , 2017, Clinical genitourinary cancer.
[14] F. Montorsi,et al. Pure but Not Mixed Histologic Variants Are Associated With Poor Survival at Radical Cystectomy in Bladder Cancer Patients , 2017, Clinical genitourinary cancer.
[15] E. Plimack,et al. Small‐Cell Carcinoma of the Bladder: 20‐Year Single‐Institution Retrospective Review , 2017, Clinical genitourinary cancer.
[16] J. Cheville,et al. High grade neuroendocrine carcinoma of the urinary bladder treated by radical cystectomy: a series of small cell, mixed neuroendocrine and large cell neuroendocrine carcinoma , 2015, Pathology.
[17] M. Amichetti,et al. Small Cell Carcinoma of the Urinary Bladder: A Retrospective, Multicenter Rare Cancer Network Study of 107 Patients. , 2015, International journal of radiation oncology, biology, physics.
[18] J. Cheville,et al. Long‐term results of radical cystectomy and role of adjuvant chemotherapy for small cell carcinoma of the bladder , 2015, International journal of urology : official journal of the Japanese Urological Association.
[19] W. Huber,et al. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2 , 2014, Genome Biology.
[20] S. Barni,et al. Correlation of pathologic complete response with survival after neoadjuvant chemotherapy in bladder cancer treated with cystectomy: a meta-analysis. , 2014, European urology.
[21] R. Millikan,et al. Neoadjuvant chemotherapy in small cell urothelial cancer improves pathologic downstaging and long-term outcomes: results from a retrospective study at the MD Anderson Cancer Center. , 2013, European urology.
[22] Xiangrong Zhao,et al. Small cell carcinoma of the urinary bladder: a rare, aggressive neuroendocrine malignancy. , 2012, Archives of pathology & laboratory medicine.
[23] T. Terada. Small cell carcinoma of the urinary bladder. , 2012, International journal of clinical and experimental pathology.
[24] A. Flesken-Nikitin,et al. Cell lineage-specific interactions between Men1 and Rb in neuroendocrine neoplasia. , 2008, Carcinogenesis.
[25] S. Groshen,et al. Radical cystectomy for primary neuroendocrine tumors of the bladder: the university of southern california experience. , 2005, The Journal of urology.
[26] J. Montie. Small cell carcinoma of the urinary bladder. A clinicopathologic analysis of 64 patients. , 2005, The Journal of urology.
[27] Ryan P. McCarthy,et al. Molecular genetic evidence for a common clonal origin of urinary bladder small cell carcinoma and coexisting urothelial carcinoma. , 2005, The American journal of pathology.
[28] C. Moran,et al. Small cell carcinoma of the bladder: a contemporary clinicopathological study of 51 cases , 2005, Histopathology.
[29] R. Millikan,et al. Evidence supporting preoperative chemotherapy for small cell carcinoma of the bladder: a retrospective review of the M. D. Anderson cancer experience. , 2004, The Journal of urology.
[30] D. Botstein,et al. Cluster analysis and display of genome-wide expression patterns. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[31] J. Crawford,et al. Randomized study of cyclophosphamide, doxorubicin, and vincristine versus etoposide and cisplatin versus alternation of these two regimens in extensive small-cell lung cancer: a phase III trial of the Southeastern Cancer Study Group. , 1992, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.